List of Chapters/Sections(Table Of Content)
1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview
1.1 Product Overview and Scope of PARP (Poly ADP-Ribose Polymerase) Inhibitor
1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Type
1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lynparza
1.2.3 Zejula
1.2.4 Rubraca
1.2.5 Talzenna
1.2.6 Other
1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Application
1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Comparison by Application: (2021-2027)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Estimates and Forecasts
1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue 2016-2027
1.4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales 2016-2027
1.4.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Region: 2016 Versus 2021 Versus 2027
2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competition by Manufacturers
2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Manufacturers (2016-2021)
2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Manufacturers (2016-2021)
2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Manufacturers (2016-2021)
2.4 Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Sites, Area Served, Product Type
2.5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competitive Situation and Trends
2.5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest PARP (Poly ADP-Ribose Polymerase) Inhibitor Players Market Share by Revenue
2.5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Retrospective Market Scenario by Region
3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures by Country
3.3.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Country
3.3.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures by Country
3.4.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Country
3.4.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures by Region
3.5.1 Asia Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Region
3.5.2 Asia Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures by Country
3.6.1 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Country
3.6.2 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures by Country
3.7.1 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Country
3.7.2 Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Historic Market Analysis by Type
4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2016-2021)
4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Type (2016-2021)
4.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Type (2016-2021)
5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Historic Market Analysis by Application
5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2016-2021)
5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Application (2016-2021)
5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Tesaro
6.2.1 Tesaro Corporation Information
6.2.2 Tesaro Description and Business Overview
6.2.3 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.2.5 Tesaro Recent Developments/Updates
6.3 Merck & Co
6.3.1 Merck & Co Corporation Information
6.3.2 Merck & Co Description and Business Overview
6.3.3 Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.3.5 Merck & Co Recent Developments/Updates
6.4 Clovis Oncology
6.4.1 Clovis Oncology Corporation Information
6.4.2 Clovis Oncology Description and Business Overview
6.4.3 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.4.5 Clovis Oncology Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GSK PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Zai Lab
6.6.1 Zai Lab Corporation Information
6.6.2 Zai Lab Description and Business Overview
6.6.3 Zai Lab PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zai Lab PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio
6.7.5 Zai Lab Recent Developments/Updates
7 PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Cost Analysis
7.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor
7.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List
8.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers
9 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Dynamics
9.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Trends
9.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Growth Drivers
9.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Challenges
9.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Restraints
10 Global Market Forecast
10.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Type (2022-2027)
10.1.2 Global Forecasted Revenue of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Type (2022-2027)
10.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Application (2022-2027)
10.2.2 Global Forecasted Revenue of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Application (2022-2027)
10.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Region (2022-2027)
10.3.2 Global Forecasted Revenue of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
